Al-Mahdili Huda A, Hooper Amanda J, Sullivan David R, Stewart Peter M, Burnett John R
Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
Ann Clin Biochem. 2006 Nov;43(Pt 6):516-9. doi: 10.1258/000456306778904650.
Abetalipoproteinaemia (ABL), an extremely rare recessive disorder, is characterized by exceptionally low or undetectable concentrations of apolipoprotein (apo) B-containing lipoproteins. ABL results from mutations in the gene encoding microsomal triglyceride transfer protein (MTP), a chaperone that facilitates the transfer of lipids onto apoB. Patients with ABL often present in childhood with a range of symptoms including fat malabsorption and manifestations of fat-soluble vitamin deficiencies. We describe a patient with sub-clinical hypothyroidism and ABL found to be compound heterozygous for a novel splice site mutation of intron 1 (c.61 + 2T > C) and a single adenine insertion in MTP exon 4 (c.419-420insA) that results in a frameshift and a protein truncated at 140 amino acids.
无β脂蛋白血症(ABL)是一种极其罕见的隐性疾病,其特征是含载脂蛋白(apo)B的脂蛋白浓度极低或无法检测到。ABL是由编码微粒体甘油三酯转移蛋白(MTP)的基因突变引起的,MTP是一种伴侣蛋白,可促进脂质转移到apoB上。ABL患者常在儿童期出现一系列症状,包括脂肪吸收不良和脂溶性维生素缺乏的表现。我们描述了一名患有亚临床甲状腺功能减退症和ABL的患者,该患者被发现为内含子1的新型剪接位点突变(c.61 + 2T > C)和MTP外显子4中的单个腺嘌呤插入(c.419-420insA)的复合杂合子,该插入导致移码和蛋白质在140个氨基酸处截断。